Document ID: chunk:federal_register_of_legislation:F2023L00496:reg:7
Version: federal_register_of_legislation:F2023L00496
Segment Type: reg
Provision Reference: reg 7
Character Range: 1684–2589

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about alpha-1 antitrypsin deficiency and death from alpha-1 antitrypsin deficiency.
Meaning of alpha-1 antitrypsin deficiency
(2)          For the purposes of this Statement of Principles, alpha-1 antitrypsin deficiency means a genetic disorder of plasma protein metabolism which involves reduced serum levels of alpha-1 antitrypsin.
Note: Common clinical manifestations include emphysema and cirrhosis of the liver.
Death from alpha-1 antitrypsin deficiency
(3)          For the purposes of this Statement of Principles, alpha-1 antitrypsin deficiency, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's alpha-1 antitrypsin deficiency.
Note: terminal event is defined in the Schedule 1 – Dictionary.